MyHealthChecked PLC Result of AGM
28 June 2024 - 7:54PM
RNS Regulatory News
RNS Number : 3759U
MyHealthChecked PLC
28 June 2024
MyHealthChecked
PLC
("MyHealthChecked" or the "Company")
Result of
AGM
MyHealthChecked PLC (AIM: MHC), the
consumer home-testing healthcare company, announces that at the Annual General
Meeting ('AGM') of the Company held earlier today, all resolutions
put to the Company's shareholders were duly passed.
|
Resolution
(*indicates special
resolution)
|
Votes
for
|
% of
shares voted
|
Votes
against
|
% of
shares voted
|
|
Resolution 1
|
8,464,640
|
99.6%
|
31,692
|
0.4%
|
|
Resolution 2
|
8,421,681
|
99.5%
|
44,241
|
0.5%
|
|
Resolution 3
|
8,425,848
|
99.2%
|
68,588
|
0.8%
|
|
Resolution 4
|
8,448,906
|
99.5%
|
45,530
|
0.5%
|
|
Resolution 5
|
1,620,012
|
95.2%
|
81,563
|
4.8%
|
|
Resolution 6*
|
1,361,538
|
80.0%
|
340,267
|
20.0%
|
|
Resolution 7*
|
8,451,080
|
99.5%
|
46,232
|
0.5%
|
Notes:
The full text of, inter alia,
the resolutions proposed and passed at the AGM can be found in the
Company's Notice of Annual General Meeting which was published and
posted to Shareholders on 4 June 2024 and is available on the
Company's website at https://investors.myhealthchecked.com/.
For
further information contact:
|
MyHealthChecked plc
|
www.myhealthchecked.com
|
|
Penny
McCormick, Chief Executive
Officer
|
via
Walbrook PR
|
|
|
|
|
SPARK Advisory Partners Limited (NOMAD)
|
Tel: +44
(0)20 3368 3550
|
|
Neil Baldwin / Jade Bayat
|
|
|
|
|
|
Dowgate Capital Limited (Broker)
|
Tel: +44
(0)20 3903 7715
|
|
David Poutney / Nicholas
Chambers
|
|
|
|
|
|
Walbrook PR Ltd (Media & IR)
|
Tel: +44
(0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com
|
|
Paul McManus / Alice
Woodings
|
Mob: +44 (0)7980 541 893 /
+44(0)7407 804 654
|
|
|
|
| |
About MyHealthChecked PLC (www.myhealthcheckedplc.com)
MyHealthChecked PLC, based in
Cardiff, is an AIM-quoted pioneering UK healthcare company focused
on a range of at-home healthcare and wellness tests.
MyHealthChecked
is the umbrella brand of a range of at-home rapid
tests, as well as DNA, RNA and blood sample collection kits which
have been created to support customers on their journeys to
wellness. The tests are lateral-flow self-tests, whilst the sample
collection kits enable the collection of blood, urine, nasal or
mouth swab samples that are analysed in partner laboratories for a
range of biomarkers. The tests have been made available online and
for over-the-counter purchase.
The MyHealthChecked portfolio has
been identified as part of a change in mindset as customers become
more familiar with the concept of accessible healthcare in the
growing at home testing kit market with a focus on accessibility at
the right price, led by UK-based experts.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
RAGQKFBPCBKKDAB
Myhealthchecked (LSE:MHC)
Historical Stock Chart
From Dec 2024 to Dec 2024
Myhealthchecked (LSE:MHC)
Historical Stock Chart
From Dec 2023 to Dec 2024
